Carregant...
Eligibility of sacubitril–valsartan in a real‐world heart failure population: a community‐based single‐centre study
AIMS: This study aims to investigate the eligibility of the Prospective Comparison of Angiotensin Receptor–Neprilysin Inhibitor (ARNI) with ACE inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM‐HF) study to a real‐world heart failure population. METHODS AND R...
Guardat en:
| Publicat a: | ESC Heart Fail |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880656/ https://ncbi.nlm.nih.gov/pubmed/29345425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12251 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|